These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2329107)

  • 21. Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.
    Panhotra BR; Saxena AK; Al-Arabi Al-Ghamdi AM
    Ann Saudi Med; 2004; 24(4):270-2. PubMed ID: 15387492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria, 1996-1999: surveillance for action.
    Marano NN; Rossiter S; Stamey K; Joyce K; Barrett TJ; Tollefson LK; Angulo FJ
    J Am Vet Med Assoc; 2000 Dec; 217(12):1829-30. PubMed ID: 11132885
    [No Abstract]   [Full Text] [Related]  

  • 23. Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin.
    Pers C; Søgaard P; Pallesen L
    Scand J Infect Dis; 1996; 28(5):529-31. PubMed ID: 8953688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar.
    Threlfall EJ; Ward LR; Skinner JA; Graham A
    Microb Drug Resist; 2000; 6(4):319-25. PubMed ID: 11272261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin in enteric fever.
    Mandal B; Flegg P; Dunbar E; Whale K; Brennand J
    Chemioterapia; 1987 Jun; 6(2 Suppl):492-3. PubMed ID: 3151350
    [No Abstract]   [Full Text] [Related]  

  • 26. Salmonellosis--an unhappy turn of events.
    Lancet; 1979 May; 1(8124):1009-10. PubMed ID: 86722
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
    Su LH; Wu TL; Chiu CH
    Clin Microbiol Infect; 2012 Apr; 18(4):E91-4. PubMed ID: 22329543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Ann Saudi Med; 2004; 24(5):332-6. PubMed ID: 15573842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of severe Salmonella typhimurium infection with ciprofloxacin.
    Dutta P; Saha MR; Mitra U; Rasaily R; Bhattacharya SK; Bhattacharya MK; Kundu B; Gupta A
    Indian Pediatr; 1995 Jul; 32(7):804-7. PubMed ID: 8617560
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in salmonellosis treatment based on in vitro susceptibilities.
    Paradelis AG; Edipides T; Zurukzoglou W
    Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):313-7. PubMed ID: 6152997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
    Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
    J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful antibiotic therapy with ciprofloxacin in pleural empyema caused by Salmonella enteritidis].
    Sion ML; Hatzitolios A; Moutafidou S; Spyridopoulos I; Ziakas G
    Med Klin (Munich); 1996 Mar; 91(3):174-6. PubMed ID: 8628205
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of salmonellosis with trimethoprim-sulphamethoxazole and their combination with polymyxin B in adult patients.
    Münnich D
    Chemotherapy; 1973; 18(2):119-29. PubMed ID: 4344081
    [No Abstract]   [Full Text] [Related]  

  • 34. [No floroquinolone resistance in non typhoidal salmonellas from hospitalized persons in an endemic area of Apulia, Italy].
    Rollo MA; Buccoliero G; Lonero G; Romanelli C; Loperfido P; Cristiano L; Chimienti A; Angelini P; Resta F
    Recenti Prog Med; 2004 Sep; 95(9):414-7. PubMed ID: 15473379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
    Ko WC; Yan JJ; Yu WL; Lee HC; Lee NY; Wang LR; Chuang YC
    Clin Infect Dis; 2005 Jan; 40(2):315-8. PubMed ID: 15655754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse of Salmonella infection after ciprofloxacin.
    Panigrahi H; Cartmill TD
    J Hosp Infect; 1992 Jan; 20(1):58. PubMed ID: 1348076
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy.
    Chang CM; Lee HC; Lee NY; Huang GC; Lee IW; Ko WC
    Pharmacotherapy; 2006 Nov; 26(11):1671-4. PubMed ID: 17064216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of quinolone resistance in salmonella: failure to prevent splenic abscess.
    Boswell TC; Coleman DJ; Purser NJ; Cobb RA
    J Infect; 1997 Jan; 34(1):86-7. PubMed ID: 9120335
    [No Abstract]   [Full Text] [Related]  

  • 39. Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure.
    Collard JM; Place S; Denis O; Rodriguez-Villalobos H; Vrints M; Weill FX; Baucheron S; Cloeckaert A; Struelens M; Bertrand S
    J Antimicrob Chemother; 2007 Jul; 60(1):190-2. PubMed ID: 17449886
    [No Abstract]   [Full Text] [Related]  

  • 40. Neonatal meningitis due to Salmonella typhimurium treated with ciprofloxacin.
    Ragunathan PL; Potkins DV; Watson JG; Kearns AM; Carroll A
    J Antimicrob Chemother; 1990 Nov; 26(5):727-8. PubMed ID: 2079456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.